Sun Pharma announced the signing of tri-party agreement between Indian Council of Medical Research, Govt of Madhya Pradesh and Foundation for Disease Elimination and Control of India (FDECINDIA) to launch the Malaria Free India demonstration project in Mandla district of Madhya Pradesh.
The Foundation for Disease Elimination and Control of India (FDEC-INDIA) has been established by Sun Pharma for disease elimination and control initiatives as part of its CSR programme.
According to the Agreement signed, NIRTH, Govt of MP and FDEC-India will jointly accomplish the goals of malaria elimination from Mandla district and prevent re-introduction by use of vector control (Indoor residual spray and/or use of insecticide treated long-lasting bednets (LLINs) and case management (rapid on-the-spot diagnosis and prompt treatment) as per national and/or WHO norms of malaria elimination efforts.
FDEC-India will be responsible for implementation of the Project in an independent manner in collaboration with NIRTH/ICMR, Govt of MP and all appropriate stakeholders. It will execute the malaria elimination project over a span of 3 to 5 years covering 1,233 villages in Mandla district. The Malaria Free India demonstration project in Mandla is expected to be launched by January 2017.
Today, the stock price closed with a loss of almost a percent at Rs 682 on the BSE.
Please rate this news :
Login below to leave a comment:
Precious Metals Preview: MCX Gold seen surging towards Rs 29K